Fairlife Milk
Company’s animal welfare claims – and brand name – face increasing scrutiny.
Combivent Respimat Asthma Inhalers
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
The Latest
CATrends: Baseball Ticket Prices
Consumers balk at hidden junk fees.
Benjamin Moore: Timeless
As years pass and life shifts, the walls around us quietly hold every moment.
Consumer Cellular
TINA.org uncovers the limits of this carrier’s “unlimited” data plans.
There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.